> top > docs > PubMed:8618456 > annotations

PubMed:8618456 JSONTXT

Annnotations TAB JSON ListView MergeView

jnlpba-st-training

Id Subject Object Predicate Lexical cue
T1 115-145 DNA denotes Translocation t(15;17)(q22;q21
T2 449-467 DNA denotes classical t(15;17)
T3 540-557 DNA denotes t(11;17)(q13;121)
T4 563-587 DNA denotes chromosome 17 breakpoint
T5 605-613 DNA denotes intron 2
T6 617-621 DNA denotes RARA
T7 714-723 DNA denotes PML locus
T8 841-845 DNA denotes RARA
T9 1117-1132 protein denotes fusion partners
T10 1136-1140 DNA denotes RARA
T11 1155-1162 protein denotes factors
T12 1221-1224 cell_type denotes PML

pubmed-sentences-benchmark

Id Subject Object Predicate Lexical cue
S1 0-114 Sentence denotes A new variant translocation in acute promyelocytic leukaemia: molecular characterization and clinical correlation.
S2 115-253 Sentence denotes Translocation t(15;17)(q22;q21) is an acquired clonal cytogenetic change present in almost all cases of acute promelocytic leukemia (APL).
S3 254-346 Sentence denotes The molecular genetic basis of the translocation supports its integral role in pathogenesis.
S4 347-468 Sentence denotes We describe a patient with APL in whom the leukaemic clone was characterized by a true variant of the classical t(15;17).
S5 469-558 Sentence denotes The patient whose disease had numerous atypical clinical features, had t(11;17)(q13;121).
S6 559-724 Sentence denotes The chromosome 17 breakpoint was localized to intron 2 of RARA by Southern blotting, and there was no evidence at the molecular level for rearrangement at PML locus.
S7 725-1071 Sentence denotes These data, along with previous reports of rare variant translocations in APL, indicate that while dysregulation of RARA by gene fusion may be essential for the APL phenotype, the particular fusion partner may determine clinicopathological aspects, including presentation, response to treatment with all-trans retinoic acid (ATRA), and prognosis.
S8 1072-1225 Sentence denotes This heterogeneity suggests that the variant fusion partners of RARA in APL encode factors with properties both common to and distinct from those of PML.
S9 1226-1361 Sentence denotes Investigation of these factors promises to shed light on the complex development pathways involved in the regulation of haematopoiesis.

genia-medco-coref

Id Subject Object Predicate Lexical cue
C1 31-60 NP denotes acute promyelocytic leukaemia
C2 115-146 NP denotes Translocation t(15;17)(q22;q21)
C3 219-252 NP denotes acute promelocytic leukemia (APL)
C4 285-302 NP denotes the translocation
C5 312-315 NP denotes its
C7 374-377 NP denotes APL
C6 359-377 NP denotes a patient with APL
C8 381-385 NP denotes whom
C9 445-467 NP denotes the classical t(15;17)
C10 469-480 NP denotes The patient
C11 481-486 NP denotes whose
C12 617-621 NP denotes RARA
C13 799-802 NP denotes APL
C14 841-845 NP denotes RARA
C15 1136-1140 NP denotes RARA
C16 1144-1147 NP denotes APL
C18 1155-1162 NP denotes factors
C19 1168-1178 NP denotes properties
C20 1212-1217 NP denotes those
C17 1155-1224 NP denotes factors with properties both common to and distinct from those of PML
C21 1243-1256 NP denotes these factors
R1 C3 C1 coref-ident acute promelocytic leukemia (APL),acute promyelocytic leukaemia
R2 C4 C2 coref-ident the translocation,Translocation t(15;17)(q22;q21)
R3 C5 C4 coref-pron its,the translocation
R4 C7 C3 coref-ident APL,acute promelocytic leukemia (APL)
R5 C8 C6 coref-relat whom,a patient with APL
R6 C9 C2 coref-ident the classical t(15;17),Translocation t(15;17)(q22;q21)
R7 C10 C6 coref-ident The patient,a patient with APL
R8 C11 C10 coref-relat whose,The patient
R9 C13 C7 coref-ident APL,APL
R10 C14 C12 coref-ident RARA,RARA
R11 C15 C14 coref-ident RARA,RARA
R12 C16 C13 coref-ident APL,APL
R13 C20 C19 coref-pron those,properties
R14 C21 C18 coref-ident these factors,factors

GENIAcorpus

Id Subject Object Predicate Lexical cue
T1 31-60 other_name denotes acute promyelocytic leukaemia
T2 115-145 DNA_domain_or_region denotes Translocation t(15;17)(q22;q21
T3 219-246 other_name denotes acute promelocytic leukemia
T4 248-251 other_name denotes APL
T5 374-377 other_name denotes APL
T6 449-467 DNA_domain_or_region denotes classical t(15;17)
T7 508-534 other_name denotes atypical clinical features
T8 540-557 DNA_domain_or_region denotes t(11;17)(q13;121)
T9 563-576 DNA_molecule denotes chromosome 17
T10 605-613 DNA_domain_or_region denotes intron 2
T11 617-621 DNA_domain_or_region denotes RARA
T12 625-642 other_name denotes Southern blotting
T13 677-692 other_name denotes molecular level
T14 697-710 other_name denotes rearrangement
T15 714-723 DNA_domain_or_region denotes PML locus
T16 799-802 other_name denotes APL
T17 841-845 DNA_domain_or_region denotes RARA
T18 849-860 other_name denotes gene fusion
T19 886-889 other_name denotes APL
T20 945-972 other_name denotes clinicopathological aspects
T21 1025-1048 other_organic_compound denotes all-trans retinoic acid
T22 1050-1054 other_organic_compound denotes ATRA
T23 1117-1132 protein_family_or_group denotes fusion partners
T24 1136-1140 DNA_domain_or_region denotes RARA
T25 1144-1147 other_name denotes APL
T26 1155-1162 protein_family_or_group denotes factors
T27 1221-1224 cell_type denotes PML
T28 1295-1315 other_name denotes development pathways
T29 1346-1360 other_name denotes haematopoiesis

PubCasesHPO

Id Subject Object Predicate Lexical cue
AB1 238-246 HP:0001909 denotes leukemia